151 related articles for article (PubMed ID: 38347556)
1. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Chronic Damage Accumulation Across Different Onset Eras in Systemic Lupus Erythematosus: A Cross-sectional Analysis of a Lupus Registry of Nationwide Institutions (LUNA).
Ohashi K; Sada KE; Asano Y; Hayashi K; Yamamura Y; Asano SH; Miyawaki Y; Morishita M; Katsuyama E; Watanabe H; Tatebe N; Narazaki M; Matsumoto Y; Sunahori-Watanabe K; Kawabata T; Yajima N; Wada J
Acta Med Okayama; 2020 Jun; 74(3):191-198. PubMed ID: 32577016
[TBL] [Abstract][Full Text] [Related]
4. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
5. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
6. Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
Hayashi K; Sada KE; Asano Y; Katayama Y; Ohashi K; Morishita M; Miyawaki Y; Watanabe H; Katsuyama T; Narazaki M; Matsumoto Y; Yajima N; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Ichinose K; Sato S; Fujiwara M; Wada J
PLoS One; 2022; 17(6):e0270569. PubMed ID: 35767524
[TBL] [Abstract][Full Text] [Related]
7. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry.
Hidekawa C; Yoshimi R; Saigusa Y; Tamura J; Kojitani N; Suzuki N; Sakurai N; Yoshioka Y; Sugiyama-Kawahara Y; Kunishita Y; Kishimoto D; Higashitani K; Sato Y; Komiya T; Nagai H; Hamada N; Maeda A; Tsuchida N; Hirahara L; Soejima Y; Takase-Minegishi K; Kirino Y; Yajima N; Sada KE; Miyawaki Y; Ichinose K; Ohno S; Kajiyama H; Sato S; Shimojima Y; Fujiwara M; Nakajima H
Front Immunol; 2023; 14():1227403. PubMed ID: 37720209
[TBL] [Abstract][Full Text] [Related]
9. Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.
Montes RA; Mocarzel LO; Lanzieri PG; Lopes LM; Carvalho A; Almeida JR
Arthritis Rheumatol; 2016 Feb; 68(2):441-8. PubMed ID: 26359794
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
Saito M; Yajima N; Yanai R; Tsubokura Y; Ichinose K; Yoshimi R; Ohno S; Sada KE
Lupus; 2021 Jun; 30(7):1146-1153. PubMed ID: 33794706
[TBL] [Abstract][Full Text] [Related]
12. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
Cobo-Ibáñez T; Urruticoechea-Arana A; Rúa-Figueroa I; Martín-Martínez MA; Ovalles-Bonilla JG; Galindo M; Calvo-Alén J; Olivé A; Fernández-Nebro A; Menor-Almagro R; Tomero E; Horcada L; Uriarte-Itzazelaia E; Martínez-Taboada VM; Andreu JL; Boteanu A; Narváez J; Bohorquez C; Montilla C; Santos G; Hernández-Cruz B; Vela P; Salgado E; Freire M; Hernández-Beriain JÁ; Díez-Álvarez E; Expósito L; Fernández-Berrizbeitia O; Velloso-Feijoo ML; Ibáñez-Barceló M; Lozano-Rivas N; Bonilla G; Moreno M; Raya E; Quevedo-Vila VE; Vázquez-Rodríguez TR; Ibáñez-Ruan J; Muñoz-Fernández S; Sánchez-Alonso F; Pego-Reigosa JM
Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
[TBL] [Abstract][Full Text] [Related]
13. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
14. Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus.
Nakai T; Fukui S; Kidoguchi G; Ikeda Y; Kitada A; Nomura A; Tamaki H; Kishimoto M; Okada M
Clin Rheumatol; 2022 Dec; 41(12):3735-3745. PubMed ID: 35939162
[TBL] [Abstract][Full Text] [Related]
15. Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study.
Yanai R; Yajima N; Oguro N; Shimojima Y; Ohno S; Kajiyama H; Ichinose K; Sato S; Fujiwara M; Miyawaki Y; Yoshimi R; Kida T; Matsuo Y; Nishimura K; Sada KE
Rheumatol Ther; 2023 Apr; 10(2):421-431. PubMed ID: 36607597
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitors in the treatment of systemic lupus erythematosus during pregnancy: A narrative review with emphasis on efficacy and safety.
Jiang Y; Tao M; Chen J; Luo L; You Q; Wu H; Zhang N
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():148-155. PubMed ID: 38245953
[TBL] [Abstract][Full Text] [Related]
17. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ
Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2018 Apr; 27(5):722-727. PubMed ID: 29087260
[TBL] [Abstract][Full Text] [Related]
19. Association of low-dose glucocorticoid use and infection occurrence in systemic lupus erythematosus patients: a prospective cohort study.
Abe K; Ishikawa Y; Kita Y; Yajima N; Inoue E; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Ichinose K; Sato S; Fujiwara M
Arthritis Res Ther; 2022 Jul; 24(1):179. PubMed ID: 35902976
[TBL] [Abstract][Full Text] [Related]
20. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
